NASDAQ:DAWN – Knox Daily

Insiders Updates

In a filing, Day One Biopharmaceuticals Inc revealed its HEAD OF R&D Blackman Samuel C. unloaded Company’s shares for reported

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Day One

Analysts Viewpoint

Day One Biopharmaceuticals Inc’s recently made public that its CHIEF EXECUTIVE OFFICER Bender Jeremy unloaded Company’s shares for reported $0.14

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Day One

Insiders Updates

In a filing, Day One Biopharmaceuticals Inc revealed its CHIEF EXECUTIVE OFFICER Bender Jeremy unloaded Company’s shares for reported $0.14

Insiders Updates

Day One Biopharmaceuticals Inc’s recently made public that its CHIEF EXECUTIVE OFFICER Bender Jeremy unloaded Company’s shares for reported $0.14

Stock Earnings

Day One Biopharmaceuticals Inc’s recently made public that its HEAD OF R&D Blackman Samuel C. unloaded Company’s shares for reported

Analysts Viewpoint

Day One Biopharmaceuticals Inc’s recently made public that its Officer SAMUEL BLACKMAN acquired Company’s shares for reported $0.43 million on

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Day One

Stock Earnings

Day One Biopharmaceuticals Inc’s filing revealed that its HEAD OF R&D Blackman Samuel C. unloaded Company’s shares for reported $0.43

Tag: NASDAQ:DAWN